List of Tables
Table 1. Plasma Protein Therapeutics Market Trends
Table 2. Plasma Protein Therapeutics Market Drivers & Opportunity
Table 3. Plasma Protein Therapeutics Market Challenges
Table 4. Plasma Protein Therapeutics Market Restraints
Table 5. Global Plasma Protein Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Plasma Protein Therapeutics Revenue Market Share by Company (2020-2025)
Table 7. Global Plasma Protein Therapeutics Sales Volume by Company (2020-2025) & (K Units)
Table 8. Global Plasma Protein Therapeutics Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Plasma Protein Therapeutics Price by Company (2020-2025) & (USD/Unit)
Table 10. Key Manufacturers Plasma Protein Therapeutics Manufacturing Base and Headquarters
Table 11. Key Manufacturers Plasma Protein Therapeutics Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Plasma Protein Therapeutics
Table 13. Global Plasma Protein Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Protein Therapeutics as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Plasma Protein Therapeutics Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Plasma Protein Therapeutics Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Plasma Protein Therapeutics Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Plasma Protein Therapeutics Sales Market Share in Value by Type (2020-2025)
Table 20. Global Plasma Protein Therapeutics Sales Market Share in Value by Type (2026-2031)
Table 21. Global Plasma Protein Therapeutics Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
Table 22. Global Plasma Protein Therapeutics Sales Volume by Type (2020-2025) & (K Units)
Table 23. Global Plasma Protein Therapeutics Sales Volume by Type (2026-2031) & (K Units)
Table 24. Global Plasma Protein Therapeutics Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Plasma Protein Therapeutics Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Plasma Protein Therapeutics Price by Type (2020-2025) & (USD/Unit)
Table 27. Global Plasma Protein Therapeutics Price by Type (2026-2031) & (USD/Unit)
Table 28. Global Plasma Protein Therapeutics Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Plasma Protein Therapeutics Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Plasma Protein Therapeutics Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Plasma Protein Therapeutics Sales Market Share in Value by Application (2020-2025)
Table 32. Global Plasma Protein Therapeutics Sales Market Share in Value by Application (2026-2031)
Table 33. Global Plasma Protein Therapeutics Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
Table 34. Global Plasma Protein Therapeutics Sales Volume by Application (2020-2025) & (K Units)
Table 35. Global Plasma Protein Therapeutics Sales Volume by Application (2026-2031) & (K Units)
Table 36. Global Plasma Protein Therapeutics Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Plasma Protein Therapeutics Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Plasma Protein Therapeutics Price by Application (2020-2025) & (USD/Unit)
Table 39. Global Plasma Protein Therapeutics Price by Application (2026-2031) & (USD/Unit)
Table 40. Global Plasma Protein Therapeutics Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Plasma Protein Therapeutics Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Plasma Protein Therapeutics Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Plasma Protein Therapeutics Sales Value by Region (2020-2025) & (%)
Table 44. Global Plasma Protein Therapeutics Sales Value by Region (2026-2031) & (%)
Table 45. Global Plasma Protein Therapeutics Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
Table 46. Global Plasma Protein Therapeutics Sales Volume by Region (2020-2025) & (K Units)
Table 47. Global Plasma Protein Therapeutics Sales Volume by Region (2026-2031) & (K Units)
Table 48. Global Plasma Protein Therapeutics Sales Volume by Region (2020-2025) & (%)
Table 49. Global Plasma Protein Therapeutics Sales Volume by Region (2026-2031) & (%)
Table 50. Global Plasma Protein Therapeutics Average Price by Region (2020-2025) & (USD/Unit)
Table 51. Global Plasma Protein Therapeutics Average Price by Region (2026-2031) & (USD/Unit)
Table 52. Key Countries/Regions Plasma Protein Therapeutics Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Plasma Protein Therapeutics Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Plasma Protein Therapeutics Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Plasma Protein Therapeutics Sales Volume, (2020-2025) & (K Units)
Table 56. Key Countries/Regions Plasma Protein Therapeutics Sales Volume, (2026-2031) & (K Units)
Table 57. Takeda Company Information
Table 58. Takeda Introduction and Business Overview
Table 59. Takeda Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Takeda Plasma Protein Therapeutics Product Offerings
Table 61. Takeda Recent Development
Table 62. CSL Company Information
Table 63. CSL Introduction and Business Overview
Table 64. CSL Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. CSL Plasma Protein Therapeutics Product Offerings
Table 66. CSL Recent Development
Table 67. Grifols Company Information
Table 68. Grifols Introduction and Business Overview
Table 69. Grifols Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Grifols Plasma Protein Therapeutics Product Offerings
Table 71. Grifols Recent Development
Table 72. Octapharma Company Information
Table 73. Octapharma Introduction and Business Overview
Table 74. Octapharma Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Octapharma Plasma Protein Therapeutics Product Offerings
Table 76. Octapharma Recent Development
Table 77. Kedrion Company Information
Table 78. Kedrion Introduction and Business Overview
Table 79. Kedrion Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Kedrion Plasma Protein Therapeutics Product Offerings
Table 81. Kedrion Recent Development
Table 82. LFB Group Company Information
Table 83. LFB Group Introduction and Business Overview
Table 84. LFB Group Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. LFB Group Plasma Protein Therapeutics Product Offerings
Table 86. LFB Group Recent Development
Table 87. Biotest Company Information
Table 88. Biotest Introduction and Business Overview
Table 89. Biotest Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Biotest Plasma Protein Therapeutics Product Offerings
Table 91. Biotest Recent Development
Table 92. BPL Company Information
Table 93. BPL Introduction and Business Overview
Table 94. BPL Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. BPL Plasma Protein Therapeutics Product Offerings
Table 96. BPL Recent Development
Table 97. RAAS Company Information
Table 98. RAAS Introduction and Business Overview
Table 99. RAAS Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. RAAS Plasma Protein Therapeutics Product Offerings
Table 101. RAAS Recent Development
Table 102. CBPO Company Information
Table 103. CBPO Introduction and Business Overview
Table 104. CBPO Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. CBPO Plasma Protein Therapeutics Product Offerings
Table 106. CBPO Recent Development
Table 107. Hualan Bio Company Information
Table 108. Hualan Bio Introduction and Business Overview
Table 109. Hualan Bio Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Hualan Bio Plasma Protein Therapeutics Product Offerings
Table 111. Hualan Bio Recent Development
Table 112. Tiantan Bio Company Information
Table 113. Tiantan Bio Introduction and Business Overview
Table 114. Tiantan Bio Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. Tiantan Bio Plasma Protein Therapeutics Product Offerings
Table 116. Tiantan Bio Recent Development
Table 117. Shuanglin Bio Company Information
Table 118. Shuanglin Bio Introduction and Business Overview
Table 119. Shuanglin Bio Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Shuanglin Bio Plasma Protein Therapeutics Product Offerings
Table 121. Shuanglin Bio Recent Development
Table 122. Boya Bio Company Information
Table 123. Boya Bio Introduction and Business Overview
Table 124. Boya Bio Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 125. Boya Bio Plasma Protein Therapeutics Product Offerings
Table 126. Boya Bio Recent Development
Table 127. Yuanda Shuyang Company Information
Table 128. Yuanda Shuyang Introduction and Business Overview
Table 129. Yuanda Shuyang Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 130. Yuanda Shuyang Plasma Protein Therapeutics Product Offerings
Table 131. Yuanda Shuyang Recent Development
Table 132. Weiguang Bio Company Information
Table 133. Weiguang Bio Introduction and Business Overview
Table 134. Weiguang Bio Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 135. Weiguang Bio Plasma Protein Therapeutics Product Offerings
Table 136. Weiguang Bio Recent Development
Table 137. Nanyue Bio Company Information
Table 138. Nanyue Bio Introduction and Business Overview
Table 139. Nanyue Bio Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 140. Nanyue Bio Plasma Protein Therapeutics Product Offerings
Table 141. Nanyue Bio Recent Development
Table 142. KM Biologics Company Information
Table 143. KM Biologics Introduction and Business Overview
Table 144. KM Biologics Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 145. KM Biologics Plasma Protein Therapeutics Product Offerings
Table 146. KM Biologics Recent Development
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Plasma Protein Therapeutics Downstream Customers
Table 150. Plasma Protein Therapeutics Distributors List
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Plasma Protein Therapeutics Product Picture
Figure 2. Global Plasma Protein Therapeutics Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Plasma Protein Therapeutics Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Plasma Protein Therapeutics Sales Volume (2020-2031) & (K Units)
Figure 5. Global Plasma Protein Therapeutics Sales Price (2020-2031) & (USD/Unit)
Figure 6. Plasma Protein Therapeutics Report Years Considered
Figure 7. Global Plasma Protein Therapeutics Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Plasma Protein Therapeutics Players Sales Volume Ranking (2024) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Plasma Protein Therapeutics Revenue in 2024
Figure 10. Plasma Protein Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Coagulation Factor Picture
Figure 12. Immune Globulin Picture
Figure 13. Albumin Picture
Figure 14. Others Picture
Figure 15. Global Plasma Protein Therapeutics Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 16. Global Plasma Protein Therapeutics Sales Value Market Share by Type, 2024 & 2031
Figure 17. Global Plasma Protein Therapeutics Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
Figure 18. Global Plasma Protein Therapeutics Sales Volume Market Share by Type, 2024 & 2031
Figure 19. Global Plasma Protein Therapeutics Price by Type (2020-2031) & (USD/Unit)
Figure 20. Product Picture of Hemophilia
Figure 21. Product Picture of PID
Figure 22. Product Picture of Others
Figure 23. Global Plasma Protein Therapeutics Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 24. Global Plasma Protein Therapeutics Sales Value Market Share by Application, 2024 & 2031
Figure 25. Global Plasma Protein Therapeutics Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
Figure 26. Global Plasma Protein Therapeutics Sales Volume Market Share by Application, 2024 & 2031
Figure 27. Global Plasma Protein Therapeutics Price by Application (2020-2031) & (USD/Unit)
Figure 28. North America Plasma Protein Therapeutics Sales Value (2020-2031) & (US$ Million)
Figure 29. North America Plasma Protein Therapeutics Sales Value by Country (%), 2024 VS 2031
Figure 30. Europe Plasma Protein Therapeutics Sales Value, (2020-2031) & (US$ Million)
Figure 31. Europe Plasma Protein Therapeutics Sales Value by Country (%), 2024 VS 2031
Figure 32. Asia Pacific Plasma Protein Therapeutics Sales Value, (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Plasma Protein Therapeutics Sales Value by Region (%), 2024 VS 2031
Figure 34. South America Plasma Protein Therapeutics Sales Value, (2020-2031) & (US$ Million)
Figure 35. South America Plasma Protein Therapeutics Sales Value by Country (%), 2024 VS 2031
Figure 36. Middle East & Africa Plasma Protein Therapeutics Sales Value, (2020-2031) & (US$ Million)
Figure 37. Middle East & Africa Plasma Protein Therapeutics Sales Value by Country (%), 2024 VS 2031
Figure 38. Key Countries/Regions Plasma Protein Therapeutics Sales Value (%), (2020-2031)
Figure 39. Key Countries/Regions Plasma Protein Therapeutics Sales Volume (%), (2020-2031)
Figure 40. United States Plasma Protein Therapeutics Sales Value, (2020-2031) & (US$ Million)
Figure 41. United States Plasma Protein Therapeutics Sales Value by Type (%), 2024 VS 2031
Figure 42. United States Plasma Protein Therapeutics Sales Value by Application (%), 2024 VS 2031
Figure 43. Europe Plasma Protein Therapeutics Sales Value, (2020-2031) & (US$ Million)
Figure 44. Europe Plasma Protein Therapeutics Sales Value by Type (%), 2024 VS 2031
Figure 45. Europe Plasma Protein Therapeutics Sales Value by Application (%), 2024 VS 2031
Figure 46. China Plasma Protein Therapeutics Sales Value, (2020-2031) & (US$ Million)
Figure 47. China Plasma Protein Therapeutics Sales Value by Type (%), 2024 VS 2031
Figure 48. China Plasma Protein Therapeutics Sales Value by Application (%), 2024 VS 2031
Figure 49. Japan Plasma Protein Therapeutics Sales Value, (2020-2031) & (US$ Million)
Figure 50. Japan Plasma Protein Therapeutics Sales Value by Type (%), 2024 VS 2031
Figure 51. Japan Plasma Protein Therapeutics Sales Value by Application (%), 2024 VS 2031
Figure 52. South Korea Plasma Protein Therapeutics Sales Value, (2020-2031) & (US$ Million)
Figure 53. South Korea Plasma Protein Therapeutics Sales Value by Type (%), 2024 VS 2031
Figure 54. South Korea Plasma Protein Therapeutics Sales Value by Application (%), 2024 VS 2031
Figure 55. Southeast Asia Plasma Protein Therapeutics Sales Value, (2020-2031) & (US$ Million)
Figure 56. Southeast Asia Plasma Protein Therapeutics Sales Value by Type (%), 2024 VS 2031
Figure 57. Southeast Asia Plasma Protein Therapeutics Sales Value by Application (%), 2024 VS 2031
Figure 58. India Plasma Protein Therapeutics Sales Value, (2020-2031) & (US$ Million)
Figure 59. India Plasma Protein Therapeutics Sales Value by Type (%), 2024 VS 2031
Figure 60. India Plasma Protein Therapeutics Sales Value by Application (%), 2024 VS 2031
Figure 61. Plasma Protein Therapeutics Industrial Chain
Figure 62. Plasma Protein Therapeutics Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
